BackgroundCheck.run
Search For

Barbara F Ehrlich, 811015 Turnstone Rd, Carlsbad, CA 92008

Known as:
Barbara Freyda Ehrlich Barb F Ehrlich Steven Ehrlich
Related to:
Christine M Gill 41 Mark Oshaughnessy Daniel G Scheidel 43 Elizabeth Mcgeorge 57 Busby O'Shaughnessy Mildred Link

Barbara Ehrlich Phones & Addresses

1015 Turnstone Rd, Carlsbad, CA 92008    760-9318234   

935 Laguna Dr, Carlsbad, CA 92008    760-4343987   

Cheshire, CT   

League City, TX   

Get Report
Control this profile

Mentions for Barbara F Ehrlich

Career records & work history

License Records

Barbara Jean Ehrlich

Licenses:
License #: 52485 - Expired
Category: Nursing Support
Issued Date: Jul 21, 2004
Effective Date: Jul 31, 2012
Expiration Date: Jul 21, 2012
Type: Medication Aide

Barbara Ehrlich resumes & CV records

Resumes

Barbara Ehrlich Photo 28

Project Manager At Technip

Position:
Project Manager at Technip
Location:
Houston, Texas
Industry:
Oil & Energy
Work:
Technip since Sep 2012
Project Manager The Shaw Group - Houston, Texas Area Mar 2006 - Sep 2012
Project Manager/ Proposal Manager Calpine Corporation - Houston, Texas Jun 2000 - Mar 2006
Director Business Development Reliant Energy Wholesale Group Feb 1982 - Jun 2000
Project Manager in Technical Sales & Support, Project Manager
Education:
Beloit College
B.A, Physics Illinois Institute of Technology
M.S, Environmental Engineering
Skills:
Power Plants, Project Engineering, Gas, Environmental Awareness, Oil/Gas, Project Management, Proposal Leadership, Proposal Writing, Budget Proposals, Refining Processes, Energy
Barbara Ehrlich Photo 29

Barbara Ehrlich

Location:
United States
Barbara Ehrlich Photo 30

Barbara Ehrlich

Location:
United States

Publications & IP owners

Us Patents

Drug Therapy To Inhibit Chemotherapy-Induced Adverse Effects And Related Pharmaceutical Compositions, Diagnostics, Screening Techniques And Kits

US Patent:
2014003, Feb 6, 2014
Filed:
Apr 27, 2012
Appl. No.:
14/112678
Inventors:
Barbara Ehrlich - New Haven CT, US
Sara Rockwell - Madison CT, US
Jennifer Benbow - Fort Mill SC, US
International Classification:
A61K 33/14
A61K 31/437
G01N 33/50
A61K 31/19
A61K 31/5415
A61K 31/337
A61K 33/00
US Classification:
424677, 514449, 514300, 424715, 514557, 5142262, 435 29
Abstract:
The invention provides a method of treatment comprising reducing therapy-induced adverse effects (TIAE), including chemotherapy-induced adverse effects (CIAE), such as chemotherapy-induced peripheral neuropathy (CIPN) and/or chemotherapy-induced cardiovascular adverse effects (CICAE) in a subject being treated with a CIAE-inducing anti-cancer active ingredient by co-administering to the subject a pharmaceutically effective amount of a NCS-1-protective composition. Related pharmaceutical compositions, diagnostics and screening techniques are also provided.

Novel Treatment For Wolfram Syndrome

US Patent:
2022034, Nov 3, 2022
Filed:
May 26, 2020
Appl. No.:
17/610041
Inventors:
- NEW HAVEN CT, US
Barbara Ehrlich - New Haven CT, US
International Classification:
A61K 31/4162
A61P 3/10
A61P 7/12
A61P 27/00
Abstract:
The present invention is directed to a novel treatment for Wolfram Syndrome or heterozygous wolframin, to methods of treatment in order to delay, inhibit, ameliorate and/or reduce the likelihood of symptomology of a patient with Wolfram Syndrome or heterozygous wolframin.

Possible Relatives

David Ehrlich  Deborah S Ehrlich  Daniel A Ehrlich  Dennis R Ehrlich  Devora Ehrlich  Diane L Ehrlich  Dimitri A Ehrlich  Barbara E Johnson  Barbara M Stander  Barbara L Standish 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.